Rubicon Research Limited Q4 FY2026 Audited Financial Results. Rubicon Research Limited, a provider of contract formulation development services to pharmaceutical companies, announced its Q4 FY2026 and FY2026 results. The Company reported a strong financial performance for the quarter and year ended March 31, 2026, with net profit for the quarter rising 112 percent. … Continue reading Rubicon Research Limited Q4 FY2026
Tag: contract formulation development
Rubicon Research IPO – Review
Rubicon Research Limited, a provider of contract formulation development services to pharmaceutical companies, is planning to raise ₹1,378 Crore through an IPO. [Fresh Issue ₹500 Cr + OFS ₹878 Cr] Rubicon research ipo price is ₹461 – ₹485 per share Rubicon Research: History The Company was originally incorporated as Rubicon Consultants Private Limited, a… Continue reading Rubicon Research IPO – Review